Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53: a target for new anticancer drugs or a target for old drugs?

Annals of oncology : official journal of the European Society for Medical Oncology - 1 Sept 1993

Brown R

Abstract excerpt

No abstract is available from the source.

Topics

Join the communities discussing this publication.

Antineoplastic Agents
DNA Damage
Genes, p53
Mutation
Tumor Suppressor Protein p53

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 8240992
DOI: 10.1093/oxfordjournals.annonc.a058614

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53: a target for new anticancer drugs or a target for old drugs?PMID 8240992Read ↗

p53 as a potential target in cancer therapy.Semantic proximity Read ↗

p53: emergency brake and target for cancer therapy.Semantic proximity Read ↗

Cancer therapy based on p53.Semantic proximity Read ↗

p53-targeted cancer pharmacotherapy: move towards small molecule compounds.Semantic proximity Read ↗

Drugging p53 in cancer: one protein, many targets.Semantic proximity Read ↗

Exploiting the p53 pathway for cancer diagnosis and therapy.Semantic proximity Read ↗

An overview of the functions of p53 and drugs acting either on wild- or mutant-type p53.Semantic proximity Read ↗

Strategies for therapeutic targeting of the p53 pathway in cancer.Semantic proximity Read ↗

Awakening guardian angels: drugging the p53 pathway.Semantic proximity Read ↗

P53 and induction of apoptosis as a target for anticancer therapy.Semantic proximity Read ↗

p53–Mdm2 inhibitors: patent review (2009 – 2010)Semantic proximity Read ↗

Cancer therapy meets p53.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.